[go: up one dir, main page]

WO2001029050A3 - Condensed pyrrole derivatives as neuraminidase inhibitors - Google Patents

Condensed pyrrole derivatives as neuraminidase inhibitors Download PDF

Info

Publication number
WO2001029050A3
WO2001029050A3 PCT/US2000/026071 US0026071W WO0129050A3 WO 2001029050 A3 WO2001029050 A3 WO 2001029050A3 US 0026071 W US0026071 W US 0026071W WO 0129050 A3 WO0129050 A3 WO 0129050A3
Authority
WO
WIPO (PCT)
Prior art keywords
neuraminidase
compounds
pyrrole derivatives
neuraminidase inhibitors
condensed pyrrole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/026071
Other languages
French (fr)
Other versions
WO2001029050A2 (en
Inventor
Clarence J Maring
David A Degoey
William J Flosi
Vincent L Giranda
Dale J Kempf
April Kennedy
Larry L Klein
Allan C Krueger
Keith F Mcdaniel
Vincent S Stoll
Minghua Sun
Chen Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to AU78312/00A priority Critical patent/AU7831200A/en
Publication of WO2001029050A2 publication Critical patent/WO2001029050A2/en
Publication of WO2001029050A3 publication Critical patent/WO2001029050A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The instant invention provides compounds of formula (I) or a pharmaceutically acceptable salt, prodrug, or ester thereof, useful in the inhibition of neuraminidase enzymes from disease-causing microorganisms, especially influenza neuraminidase, pharmaceutical formulations containing same, processes and intermediates for preparing said compounds, as well as methods of using said compounds, including preventing and treating diseases caused by microorganisms having said neuraminidase enzyme.
PCT/US2000/026071 1999-10-19 2000-09-22 Condensed pyrrole derivatives as neuraminidase inhibitors Ceased WO2001029050A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78312/00A AU7831200A (en) 1999-10-19 2000-09-22 Neuraminidase inhibitors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41986899A 1999-10-19 1999-10-19
US09/419,868 1999-10-19
US42802199A 1999-10-27 1999-10-27
US09/428,021 1999-10-27

Publications (2)

Publication Number Publication Date
WO2001029050A2 WO2001029050A2 (en) 2001-04-26
WO2001029050A3 true WO2001029050A3 (en) 2001-11-22

Family

ID=27024654

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/026071 Ceased WO2001029050A2 (en) 1999-10-19 2000-09-22 Condensed pyrrole derivatives as neuraminidase inhibitors

Country Status (2)

Country Link
AU (1) AU7831200A (en)
WO (1) WO2001029050A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3189771A1 (en) * 2020-07-22 2022-01-27 Janssen Pharmaceutica Nv Compounds useful as factor xia inhibitors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558321A1 (en) * 1992-02-27 1993-09-01 Sanwa Kagaku Kenkyusho Co., Ltd. Antivirally active N-cycloalkyl alkanol compounds
US5962467A (en) * 1995-06-07 1999-10-05 Glycodesign, Inc. Derivatives of swainsonine and their use as therapeutic agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558321A1 (en) * 1992-02-27 1993-09-01 Sanwa Kagaku Kenkyusho Co., Ltd. Antivirally active N-cycloalkyl alkanol compounds
US5962467A (en) * 1995-06-07 1999-10-05 Glycodesign, Inc. Derivatives of swainsonine and their use as therapeutic agents

Also Published As

Publication number Publication date
AU7831200A (en) 2001-04-30
WO2001029050A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
WO2001028996A3 (en) Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
EP1090908A3 (en) Cyclobutane derivatives as inhibitors of protein farnesyltransferase
CA2367017A1 (en) Inhibitors of impdh enzyme
AU2829292A (en) Saccharin derivative proteolytic enzyme inhibitors
AU6328094A (en) Saccharin derivative proteolytic enzyme inhibitors
WO2002060879A3 (en) Bacterial gyrase inhibitors and uses thereof
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
YU74002A (en) Percyquinnin, a process for its production and its use as a pharmaceutical
WO2001096307A3 (en) Cycloalkyl alkanoic acids as integrin receptor antagonists
EA200000355A2 (en) INDUSTRIAL PRODUCTS
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
DE69905131D1 (en) Isochroman compounds and processes for their production
WO2001000617A3 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
AU7270798A (en) Antithrombotic agents
IL141212A0 (en) Process for the synthesis of (1h)-benzo [c] quinolizin-3-one derivatives
BR9909870A (en) Pyrrolidines as inhibitors of neuraminidases
WO2001028979A3 (en) Inhibitors of neuraminidases
NO983444L (en) Benzo (c) quinolizine derivatives, their preparation and use as 5 <alfa> reductase inhibitors
WO2001029050A3 (en) Condensed pyrrole derivatives as neuraminidase inhibitors
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
BR0010525A (en)  1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1carboxylates as neuraminidase inhibitors
AU2002362008A1 (en) Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
WO2002018363A3 (en) 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0010631

Country of ref document: BR

Free format text: PEDIDO CONSIDERADO RETIRADO EM RELACAO AO BRASIL, POR TER SIDO A FASE NACIONAL INTEMPESTIVA.